Free Trial

ReShape Lifesciences (RSLS) Short Interest Ratio & Short Volume

ReShape Lifesciences logo
$0.41 -0.04 (-9.40%)
As of 11:52 AM Eastern

ReShape Lifesciences Short Interest Data

ReShape Lifesciences (RSLS) has a short interest of 367,200 shares, representing 50.37% of the float (the number of shares available for trading by the public). This marks a -22.14% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 1.71 million shares to cover all short positions.

Current Short Interest
367,200 shares
Previous Short Interest
471,600 shares
Change Vs. Previous Month
-22.14%
Dollar Volume Sold Short
$233,355.60
Short Interest Ratio
0.3 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
3,305,000 shares
Short Percent of Float
50.37%
Today's Trading Volume
5,236,029 shares
Average Trading Volume
1,712,674 shares
Today's Volume Vs. Average
306%
Short Selling ReShape Lifesciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ReShape Lifesciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RSLS Short Interest Over Time

RSLS Days to Cover Over Time

RSLS Percentage of Float Shorted Over Time

Remove Ads

ReShape Lifesciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025367,200 shares $233,355.60 -22.1%50.4%0.3 $0.64
2/28/2025471,600 shares $485,748.00 +469.6%64.7%0.4 $1.03
2/15/202582,800 shares $192,924.00 +266.4%62.6%0.1 $2.33
1/31/202522,600 shares $86,897.00 +40.4%3.3%0.4 $3.85
1/15/202516,100 shares $79,373.00 -13.0%2.3%0.2 $4.93
12/31/202418,500 shares $82,510.00 -38.1%2.7%0.2 $4.46
12/15/202429,900 shares $141,128.00 +25.6%4.4%0.3 $4.72
11/30/202423,800 shares $141,372.00 -70.9%3.6%0.1 $5.94
11/15/202481,700 shares $428,108.00 +226.8%12.4%0.4 $5.24
10/31/202425,000 shares $141,250.00 +70.1%5.3%0.1 $5.65
10/15/202414,700 shares $83,202.00 -74.3%3.1%0.1 $5.66
9/30/202457,200 shares $323,180.00 +472.0%12.2%0.4 $5.65
9/15/202410,000 shares $1,678.00 -98.3%N/A0.1 $0.17
8/31/2024585,200 shares $94,217.20 -26.0%2.2%0.4 $0.16
8/15/2024791,000 shares $139,295.10 +16.3%3.0%0.1 $0.18
7/31/2024680,000 shares $132,668.00 -60.5%2.6%0.1 $0.20
7/15/20241,720,000 shares $391,644.00 +272.0%6.6%0.3 $0.23
6/30/2024462,400 shares $88,595.84 +104.2%2.2%0.1 $0.19
6/15/2024226,500 shares $44,348.70 -89.6%1.1%0 $0.20
5/31/20242,170,000 shares $553,133.00 +598.7%10.4%0.4 $0.25
5/15/2024310,600 shares $54,044.40 -11.3%1.5%0.5 $0.17
4/30/2024350,100 shares $58,116.60 -28.2%1.7%0.8 $0.17
4/15/2024487,800 shares $80,238.22 -33.1%2.3%0.9 $0.16
3/31/2024729,300 shares $134,482.92 +70.1%3.5%0.9 $0.18
3/15/2024428,700 shares $69,663.75 -43.3%2.1%0.4 $0.16
2/29/2024756,200 shares $127,268.46 -9.0%4.0%0.1 $0.17
2/15/2024830,800 shares $143,063.76 -3.7%4.4%0.2 $0.17
1/31/2024862,400 shares $180,327.84 -41.3%4.6%0.2 $0.21
1/15/20241,470,000 shares $378,672.00 +102.2%14.0%0.2 $0.26
12/31/2023726,900 shares $181,506.93 -93.6%5.6%0.1 $0.25
12/15/202311,270,000 shares $3.73 million +5,386.9%86.9%1.5 $0.33
11/30/2023205,400 shares $46,851.74 -66.6%1.6%0.1 $0.23
11/15/2023614,800 shares $150,195.64 -63.2%4.7%0.2 $0.24
10/31/20231,670,000 shares $413,659.00 +77.7%14.0%0.5 $0.25
10/15/2023939,900 shares $284,601.72 +178.7%7.9%0.5 $0.30
9/30/2023337,300 shares $114,007.40 +112.8%2.8%1.5 $0.34
9/15/2023158,500 shares $118,082.50 +335.4%4.8%1.1 $0.75
8/31/202336,400 shares $33,855.64 +658.3%1.1%0.2 $0.93
8/15/20234,800 shares $5,712.00 -79.1%0.2%0 $1.19
7/31/202323,000 shares $32,660.00 +12.2%0.8%0.1 $1.42
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

7/15/202320,500 shares $30,750.00 -74.8%0.7%0.1 $1.50
6/30/202381,300 shares $120,324.00 +95.0%2.9%0.3 $1.48
6/15/202341,700 shares $91,740.00 -59.6%1.5%0.1 $2.20
5/31/2023103,100 shares $249,502.00 -7.9%3.7%0.4 $2.42
5/15/2023111,900 shares $275,274.00 -11.8%4.0%0.4 $2.46
6/15/2021100 shares $213.33 No ChangeN/A0.1 $2.13
5/28/2021100 shares $620.00 No ChangeN/A0.1 $6.20
4/15/2021100 shares $440.00 No ChangeN/A0.2 $4.40
3/31/2021100 shares $420.00 No ChangeN/A0.1 $4.20
2/12/20211,000 shares $9,000.00 +150.0%N/A0.3 $9.00
1/29/2021400 shares $2,486.40 +300.0%N/A0 $6.22
1/15/2021100 shares $400.00 No ChangeN/A0.1 $4.00
12/31/2020100 shares $375.00 No ChangeN/A0.2 $3.75
12/15/2020100 shares $445.00 No ChangeN/A0.1 $4.45
11/30/2020100 shares $445.00 No ChangeN/A0.5 $4.45
11/15/2020100 shares $410.00 No ChangeN/A0.1 $4.10
10/30/2020100 shares $345.00 No ChangeN/A0.1 $3.45
10/15/2020100 shares $350.00 No ChangeN/A0.3 $3.50
9/30/2020100 shares $400.00 No ChangeN/A0 $4.00
9/15/2020100 shares $325.00 No ChangeN/A0.1 $3.25
8/31/2020100 shares $468.00 No ChangeN/A0 $4.68
8/14/2020100 shares $261.00 No ChangeN/A0.1 $2.61
7/31/2020100 shares $269.00 No ChangeN/A0 $2.69
7/15/2020100 shares $300.00 No ChangeN/A0 $3.00
6/30/2020100 shares $380.00 No ChangeN/A0.1 $3.80
6/15/2020100 shares $385.00 No ChangeN/A0.2 $3.85
5/29/2020100 shares $410.00 No ChangeN/A0.1 $4.10
5/15/2020100 shares $450.00 No ChangeN/A0.3 $4.50
4/30/2020100 shares $452.00 No ChangeN/A0.1 $4.52

RSLS Short Interest - Frequently Asked Questions

What is ReShape Lifesciences' current short interest?

Short interest is the volume of ReShape Lifesciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 367,200 shares of RSLS short. 50.37% of ReShape Lifesciences' shares are currently sold short. Learn More on ReShape Lifesciences' current short interest.

What is a good short interest percentage for ReShape Lifesciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 50.37% of ReShape Lifesciences' floating shares are currently sold short.

Is ReShape Lifesciences' short interest increasing or decreasing?

ReShape Lifesciences saw a decrease in short interest in March. As of March 15th, there was short interest totaling 367,200 shares, a decrease of 22.1% from the previous total of 471,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ReShape Lifesciences' short interest compare to its competitors?

50.37% of ReShape Lifesciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ReShape Lifesciences: Abbott Laboratories (1.27%), Intuitive Surgical, Inc. (1.37%), Boston Scientific Co. (0.86%), Stryker Co. (1.49%), Medtronic plc (1.00%), Becton, Dickinson and Company (1.00%), Edwards Lifesciences Co. (1.64%), IDEXX Laboratories, Inc. (3.75%), ResMed Inc. (5.99%), DexCom, Inc. (2.94%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short ReShape Lifesciences stock?

Short selling RSLS is an investing strategy that aims to generate trading profit from ReShape Lifesciences as its price is falling. RSLS shares are trading down $1.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ReShape Lifesciences?

A short squeeze for ReShape Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RSLS, which in turn drives the price of the stock up even further.

How often is ReShape Lifesciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSLS, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:RSLS) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners